Press Releases

April 28, 2006

Gilead Sciences to Present at Two Upcoming Investor Conferences

FOSTER CITY, Calif.--(BUSINESS WIRE)--April 28, 2006--Gilead Sciences, Inc. (Nasdaq:GILD):

Deutsche Bank 31st Annual Healthcare Conference on May 2nd
Morgan Stanley Global Healthcare Unplugged Conference on May 3rd
Webcasts Available Through Gilead Corporate Website

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its corporate presentation will be webcast at two upcoming investor conferences: the Deutsche Bank 31st Annual Healthcare Conference, in Boston, Massachusetts, and the Morgan Stanley Global Healthcare Unplugged Conference, in Miami, Florida. These webcasts may be accessed via the company's corporate website at www.gilead.com.

John Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of the company and an update on key business milestones first at the Deutsche Bank conference on Tuesday, May 2nd at 10:30 a.m. Eastern Time, then again at the Morgan Stanley conference on Wednesday, April 3rd at 9:30 a.m. Eastern Time.

To access the live webcasts via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)
SOURCE: Gilead Sciences, Inc.